Director/PDMR Shareholding - Replacement
Updated : 14:30
The following amendment has been made to the Director/PDMR Shareholding announcement released on 8 January 2020 at 17:04 under RNS No. 2088Z:
Daemmon Reeve's resultant interest in Ordinary Shares should have read 492,325.
All other details remain unchanged. The full amended text is shown below:
TREATT PLC
("Treatt" or "the Company")
Notification of Transactions of Directors
In accordance with the requirements of the EU Market Abuse Regulation, the Company received notification on 6 January 2020 of the following transactions.
An award granted pursuant to the 2014 Long Term Incentive Plan ("2014 LTIP") to Daemmon Reeve, Chief Executive Officer, in 2016 vested in full on 12 December 2019, was subject to performance criteria based upon the average annual growth in pre-exceptional basic earnings per share over a three-year period, and has subsequently been exercised.
This exercise is detailed below, including the number of ordinary share of 2 pence each in the Company ("Ordinary Shares") sold by Daemmon Reeve at a volume weighted average price of £4.67 per share to satisfy the tax and national insurance liabilities and administrative fees arising on exercise:
Ordinary Shares received pursuant to 2014 LTIP | Ordinary Shares sold | Resultant interest in Ordinary Shares | Resultant % holding in total issued share capital |
| |||
Daemmon Reeve | CEO | 104,354 | 49,046 | 492,325 | 0.83% |
Contact details
Anita Guernari
Company Secretary
++ 44 1284 770028
1 | Details of the person discharging managerial responsibilities / person closely associated | ||
a) | Name | Daemmon Reeve | |
2 | Reason for the notification | ||
a) | Position/status | CEO | |
b) | Initial notification/Amendment | Initial Notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Treatt Plc | |
b) | LEI | 213800G40JM9F7G9LG39 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 2 pence each
GB00BKS7YK08 | |
b) | Nature of transaction | Exercise of 2016 LTIP | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
nil cost | 104,354 | ||
d) | Aggregated information - Aggregated volume - Price
| N/A (Single transaction) | |
e) | Date of the transaction | 6 January 2020 | |
f) | Place of the transaction | Outside a trading Venue | |
1 | Details of the person discharging managerial responsibilities / person closely associated | ||
a) | Name | Daemmon Reeve | |
2 | Reason for the notification | ||
a) | Position/status | CEO | |
b) | Initial notification/Amendment | Initial Notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Treatt Plc | |
b) | LEI | 213800G40JM9F7G9LG39 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 2 pence each
GB00BKS7YK08 | |
b) | Nature of transaction | Sale of Ordinary Shares to satisfy tax and national insurance liabilities | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
a) £4.69 b) £4.66
| a) 11,834 b) 37,212 | ||
d) | Aggregated information - Aggregated volume - Price
|
49,046 £4.67 | |
e) | Date of the transaction | 6 January 2020 | |
f) | Place of the transaction | London Stock Exchange, XLON | |
END
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.